Supernus Pharmaceuticals (SUPN) Intangibles (2011 - 2026)
Supernus Pharmaceuticals (SUPN) reported Intangibles of $469.46 million for Q2 2026, down 2.5% from $481.31 million a year earlier and down 14.6% from the prior quarter.
Supernus Pharmaceuticals (SUPN) Intangibles (2011 - 2026) Analysis & Trends
At the end of FY2025, Supernus Pharmaceuticals posted Intangibles of $569.46 million, up 9.1% from FY2024.
- Intangibles has a five-year compound annual growth rate of 9.3% (FY2020 to FY2025).
- By year, Intangibles came in at $521.91 million in FY2024 (-13.0%), $599.89 million in FY2023 (-14.6%), $702.46 million in FY2022 (-10.5%) and $784.69 million in FY2021 (+115.4%).
- The Q2 2026 figure ranks as the lowest quarterly Intangibles since Q3 2021.
- Year over year, Intangibles gained in three of the last eight quarters, with an average decline of 3.1%.
- The high point for year-over-year Intangibles in five years was Q4 2021 (growth of 115.4%); the low point was Q3 2024 (a decline of 15.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $549.71 million (Q1 2026), $569.46 million (Q4 2025) and $623.48 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Supernus Pharmaceuticals | 2.40 Bn | 1.06 Bn | 185.39 Mn | 469.46 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 469.46 Mn |
| Mar 31, 2026 | 549.71 Mn |
| Dec 31, 2025 | 569.46 Mn |
| Sep 30, 2025 | 623.48 Mn |
| Jun 30, 2025 | 481.31 Mn |
| Mar 31, 2025 | 502.13 Mn |
| Dec 31, 2024 | 521.91 Mn |
| Sep 30, 2024 | 540.16 Mn |
| Jun 30, 2024 | 559.64 Mn |
| Mar 31, 2024 | 579.75 Mn |
| Dec 31, 2023 | 599.89 Mn |
| Sep 30, 2023 | 641.15 Mn |
| Jun 30, 2023 | 662.39 Mn |
| Mar 31, 2023 | 682.50 Mn |
| Dec 31, 2022 | 702.46 Mn |
| Sep 30, 2022 | 722.76 Mn |
| Jun 30, 2022 | 743.41 Mn |
| Mar 31, 2022 | 764.05 Mn |
| Dec 31, 2021 | 784.69 Mn |
| Sep 30, 2021 | 346.62 Mn |
Supernus Pharmaceuticals Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=SUPN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();